Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The Europe Spirometer Market is expected to reach USD 349.25 million by 2024, from USD 177.79 million in 2016 growing at a CAGR of 8.9% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.
The key market players for Europe Spirometer Market are listed below:
• BD,
• Midmark Corp
• Welch allyn
• SDI Diagnostics,
• Geratherm Respiratory GMBH,
The market is further segmented into:
• Type
• Application
• End User
• Geography
The Europe spirometer market is segmented on the basis of product type, technology, disease, disposable components, application, end-user and distribution channel. On the basis of product type, the Europe spirometer market is segmented into table-top spirometer, hand-held spirometer and pc based spirometer.
Based on technology, the Europe spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Europe spirometer market with 68.4% market share and is expected to reach USD 244.9 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.
Based on, the Europe spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Europe spirometer market with 42.7% market share and is expected to reach USD 154.0 million by 2024, growing with the highest CAGR of 9.4% in the forecast period 2017 to 2024.
Based on disposable components, the Europe spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Europe spirometer market with 75.0% market share and is expected to reach USD 265.4 million by 2024, growing with the highest CAGR of 9.1% in the forecast period 2017 to 2024.
Based on application, the Europe spirometer market is segmented into diagnostics and therapeutics. In 2017, diagnostics is expected to dominate the Europe spirometer market with 65.8% market share and is expected to reach USD 238.1 million by 2024, growing with the highest CAGR of 9.5% in the forecast period 2017 to 2024.
Based on end-user, the Europe spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Europe spirometer market with 51.0% market share and is expected to reach USD 183.7 million by 2024, growing at a CAGR of 9.4% in the forecast period 2017 to 2024.
Based on distribution channel, the Europe spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Europe spirometer market with 65.1% market share and is expected to reach USD 232.3 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.
Based on geography, the Europe Spirometer market is segmented into 11 geographical regions, such as,
• Germany,
• France,
• United Kingdom,
• Italy,
• Spain,
• Russia,
• Turkey,
• Belgium,
• Netherlands,
• Switzerland,
• Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.
The key market players for Europe Spirometer Market are listed below:
• BD,
• Midmark Corp
• Welch allyn
• SDI Diagnostics,
• Geratherm Respiratory GMBH,
The market is further segmented into:
• Type
• Application
• End User
• Geography
The Europe spirometer market is segmented on the basis of product type, technology, disease, disposable components, application, end-user and distribution channel. On the basis of product type, the Europe spirometer market is segmented into table-top spirometer, hand-held spirometer and pc based spirometer.
Based on technology, the Europe spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Europe spirometer market with 68.4% market share and is expected to reach USD 244.9 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.
Based on, the Europe spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Europe spirometer market with 42.7% market share and is expected to reach USD 154.0 million by 2024, growing with the highest CAGR of 9.4% in the forecast period 2017 to 2024.
Based on disposable components, the Europe spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Europe spirometer market with 75.0% market share and is expected to reach USD 265.4 million by 2024, growing with the highest CAGR of 9.1% in the forecast period 2017 to 2024.
Based on application, the Europe spirometer market is segmented into diagnostics and therapeutics. In 2017, diagnostics is expected to dominate the Europe spirometer market with 65.8% market share and is expected to reach USD 238.1 million by 2024, growing with the highest CAGR of 9.5% in the forecast period 2017 to 2024.
Based on end-user, the Europe spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Europe spirometer market with 51.0% market share and is expected to reach USD 183.7 million by 2024, growing at a CAGR of 9.4% in the forecast period 2017 to 2024.
Based on distribution channel, the Europe spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Europe spirometer market with 65.1% market share and is expected to reach USD 232.3 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.
Based on geography, the Europe Spirometer market is segmented into 11 geographical regions, such as,
• Germany,
• France,
• United Kingdom,
• Italy,
• Spain,
• Russia,
• Turkey,
• Belgium,
• Netherlands,
• Switzerland,
• Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
